ARAna R. Rubio

Ana R. Rubio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana R. Rubio has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Role of Seroalbumin in the Cytotoxicity ofcis-Dichloro Pt(II) Complexes with (N^N)-Donor Ligands Bearing Functionalized Tails

    by Cristina Pérez-Arnaiz, Jorge Leal, Natalia Busto, María C. Carrión, Ana R. Rubio, Imanol Ortiz, Giampaolo Barone, Borja Díaz de Greñu, Javier Santolaya, José M. Leal, et al.

    Given the potent anticancer properties of cis-diamminedichloroplatinum(II) and knowing its mode of action, we synthesized four new cis-[PtCl2(N^N)] organoplatinum complexes, two with N-substituted pbi ligands (pbiR = 1-R-2-(2-pyridyl)benzimidazole) (namely, 1 and 2) and two more with 4,4′-disubstituted bpy ligands (bpy = 2,2′-bipyridine) (namely, 3 and 4). We explored their cytotoxicity and ability to bind to deoxyguanosine monophosphate (dGMP), DNA, and albumin models. By 1H NMR and UV–vis spectroscopies, circular dichroism, agarose gel electrophoresis, differential scanning calorimetry measurements, and density functional theory calculations, we verified that only 3 can form aquacomplex species after dimethyl sulfoxide solvation; surprisingly, 1, 2, and 3 can bind covalently to DNA, whereas 4 can form a noncovalent complex. Interestingly, only complexes 1 and 4 exhibit good cytotoxicity against human ovarian carcinoma (HeLa) cell line, whereas 2 and 3 are inactive. Although lung carcinoma (A549) cells are more resistant to the four platinum complexes than HeLa cells, when the protein concentration in the extracellular media is lower, the cytotoxicity becomes substantially enhanced. By native electrophoresis of bovine seroalbumin (BSA) and inductively coupled plasma mass spectrometry uptake studies we bear out, on one hand, that 2 and 3 can interact strongly with BSA and its cellular uptake is negligible and, on the other hand, that 1 and 4 can interact with BSA only weakly, its cellular uptake being higher by several orders. These results point up the important role of the protein binding features on their biological activity and cellular uptake of cis-“PtCl2” derivatives. Our results are valuable in the future rational design of new platinum complexes with improved biological properties, as they expose the importance not only of their DNA binding abilities but also of additional factors such as protein binding.


  • Doxorubicin binds to duplex RNA with higher affinity than ctDNA and favours the isothermal denaturation of triplex RNA

    by Ana R. Rubio, Natalia Busto, José M. Leal, Begoña García

    The interaction of doxorubicin (DOX) with triplex, duplex and single RNA helices has been studied by fluorimetric, circular dichroism, viscometry, DSC, ITC, T-jump kinetic relaxation technique and fluorescence lifetime measurements in near physiological conditions (pH = 7, I = 0.1 M and 25 °C). DOX binds to the groove of poly(rA)·2poly(rU), while it intercalates into poly(rA)·poly(rU) and forms external complex with poly(rA) and poly(rU). Fluorescence lifetime measurements have shown that all the RNA/DOX complexes are non-fluorescent. The affinity with the duplex is some 15 times greater than with the triplex; this behaviour favours the isothermal denaturation of the triplex/DOX complex according to reaction poly(rA)·2poly(rU)/DOX + DOX ⇌ poly(rA)·poly(rU)/DOX + poly(rU)/DOX, that is, the reaction shifts to right upon increasing the DOX content. ITC measurements have revealed that, under the same conditions, the affinity of DOX with the RNA duplex is higher than with ctDNA, a striking outcome as long as the binding of DOX to DNA seems to be the origin of its biological action.